Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ALS drug shows promise in Mid-Stage trial

NCT ID NCT06365216

Ongoing Disease control Sponsor: Axoltis Pharma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called NX210c in 80 adults with ALS, a nerve disease that weakens muscles over time. Participants receive multiple IV infusions of the drug or a placebo to see if it slows the disease and is safe. The main focus is on changes in blood markers that reflect nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMYOTROPHIC LATERAL SCLEROSIS

Contacts and locations

Locations

  • CHRU De Nancy

    Nancy, France, 54000, France

  • CHU de Lyon HCL

    Bron, 69500, France

  • Centre Hospitalier Et Universitaire de Limoges

    Limoges, 87042, France

  • Centre Hospitalier Regional Et Universitaire De Brest

    Brest, France, 29200, France

  • Centre Hospitalier Regional Universitaire de Tours

    Tours, 37044, France

  • Centre Hospitalier Universitaire De Bordeaux

    Bordeaux, 33000, France

  • Centre Hospitalier Universitaire De Caen Normandie

    Caen, France, 14033, France

  • Centre Hospitalier Universitaire d'Angers

    Angers, 49100, France

  • Centre Hospitalier Universitaire de Clermont-Ferrand - Hôpital Gabriel Montpied

    Clermont-Ferrand, 63003, France

  • Centre Hospitalier Universitaire de Lille

    Lille, 59037, France

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, 34295, France

  • Centre Hospitalier Universitaire de Nantes - Hôpital Nord Laennec

    Nantes, 44093, France

  • Centre Hospitalier Universitaire de Nice

    Nice, 06000, France

  • Centre Hospitalier Universitaire de Rennes

    Rennes, 35000, France

  • Hôpital La Timone - APHM

    Marseille, France, 13005, France

  • Hôpital de la Pitié Salpêtrière

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.